Harold Bernstein sold $252K of Maze Therapeutics (MAZE)

Executed Sep 2, disclosed Sep 4, 2 days later.

Value, as filed

$252K

9,611 sh across 2 lots

Executed

Sep 2

the trade date, as filed

Disclosed

Sep 4

2 days after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

Harold Bernstein President, R&D & CMO profile →

Harold Bernstein (President, R&D & CMO) filed 14 Form 4 reports in the trailing twelve months (0 purchases, 14 sales), most often in Maze Therapeutics, Inc. (MAZE). The largest single filing was $1.8M of MAZE (45,000 sh across 2 lots, as filed), executed Dec 29 2025.

The name

MAZE

Maze Therapeutics, Inc. MAZE · Healthcare · 36 filings in 24 months ticker →

Healthcare · Maze Therapeutics, Inc., a clinical stage biopharmaceutical company, develops small molecule precision medicines for the treatment of kidne…

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by Harold Bernstein in MAZE

MAZESALE Maze Therapeutics, Inc. $255K
9,705 sh × $26.22
Exec Sep 4
Filed Sep 8 · 4:20 PM ET MAZESALE Maze Therapeutics, Inc. $426K
16,141 sh × $26.36
Exec Sep 1
Filed Sep 3 · 4:24 PM ET MAZESALE Maze Therapeutics, Inc. $446K
16,142 sh × $27.61
Exec Aug 13
Filed Aug 14 · 4:54 PM ET MAZESALE Maze Therapeutics, Inc. $400K
13,409 sh × $29.86
Exec Jul 1
Filed Jul 2 · 4:29 PM ET MAZESALE Maze Therapeutics, Inc. $339K
13,253 sh × $25.57
Exec Jun 1
Filed Jun 3 · 5:30 PM ET MAZESALE Maze Therapeutics, Inc. $393K
15,000 sh × $26.22
Exec May 14
Filed May 18 · 5:30 PM ET MAZESALE Maze Therapeutics, Inc. $433K
14,700 sh across 2 lots
Exec Apr 1
Filed Apr 2 · 5:30 PM ET MAZESALE Maze Therapeutics, Inc. $736K
15,000 sh across 3 lots
Exec Mar 20
Filed Mar 20 · 5:30 PM ET